APA (7th ed.) Citation

I, Y., U, T., & A, D. (2026). Immune checkpoint inhibitors in pediatric central nervous system tumors: Biology, clinical experience, and translational pathways to precision immunotherapy. Journal of neuro-oncology, 177(1), . https://doi.org/10.1007/s11060-026-05491-w

Chicago Style (17th ed.) Citation

I, Yenidogan, Tabori U, and Das A. "Immune Checkpoint Inhibitors in Pediatric Central Nervous System Tumors: Biology, Clinical Experience, and Translational Pathways to Precision Immunotherapy." Journal of Neuro-oncology 177, no. 1 (2026). https://doi.org/10.1007/s11060-026-05491-w.

MLA (9th ed.) Citation

I, Yenidogan, et al. "Immune Checkpoint Inhibitors in Pediatric Central Nervous System Tumors: Biology, Clinical Experience, and Translational Pathways to Precision Immunotherapy." Journal of Neuro-oncology, vol. 177, no. 1, 2026, https://doi.org/10.1007/s11060-026-05491-w.